- The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while “artificially” inflating costs for patients.
- The suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts, and their affiliated group purchasing organizations.
- The FTC may also recommend suing insulin manufacturers Eli Lilly, Sanofi and Novo Nordisk in the future.
You must log in or register to comment.
Yes, Please. These fuckers are the devil. Sue them into oblivion. Rip the dollars out of their bloody hands.
Kahn is the real deal. I hope Harris keeps her and gives her anything she asks for.
Lina Kahn could be the trust buster we need to get America’s shit together and maybe reign in some of these big businesses that seem to be completely above the law.
Kahn is the real deal.
It’s Khan
Khaaaaaan!
We also need to stop Republicans from constantly trying (and sometimes succeeding) to strip the FTC of its powers to enforce issues/laws/regulations well within its scope as a federal agency.
Whatever her budget is, double it.
And send here a case of whatever she’s drinking
pharmabros be like
This is why I vote blue no matter who, right here.
Noice
